Success Metrics

Clinical Success Rate
75.0%

Based on 3 completed trials

Completion Rate
75%(3/4)
Active Trials
1(10%)
Results Posted
0%(0 trials)
Terminated
1(10%)

Phase Distribution

Ph phase_4
1
10%
Ph early_phase_1
1
10%
Ph not_applicable
7
70%

Phase Distribution

1

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution9 total trials
Early Phase 1First-in-human
1(11.1%)
Phase 4Post-market surveillance
1(11.1%)
N/ANon-phased studies
7(77.8%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

60.0%

3 of 5 finished

Non-Completion Rate

40.0%

2 ended early

Currently Active

1

trials recruiting

Total Trials

10

all time

Status Distribution
Active(2)
Completed(3)
Terminated(2)
Other(3)

Detailed Status

unknown3
Completed3
Recruiting1
Not yet recruiting1
Withdrawn1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
10
Active
1
Success Rate
75.0%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (11.1%)
Phase 41 (11.1%)
N/A7 (77.8%)

Trials by Status

recruiting110%
not_yet_recruiting110%
unknown330%
withdrawn110%
terminated110%
completed330%

Recent Activity

Clinical Trials (10)

Drug Details

Intervention Type
OTHER
Total Trials
10